In vitro stimulation with overlapping peptides encoding MAGE-A3 and MAGE-A4 was shown to induce specific CD4(+) T cells in all seven HNSCC patients evaluated [105]. This evidence concerns the gene MAGEA4 and head and neck squamous cell carcinoma.